| Literature DB >> 32502132 |
Venkatesan Thiruvenkatarajan1,2, David T Wong3, Harikrishnan Kothandan4, Vimal Sekhar1, Sanjib Das Adhikary5, John Currie1, Roelof M Van Wijk1,4.
Abstract
Current evidence suggests that coronavirus disease 2019 (COVID-19) spread occurs via respiratory droplets (particles >5 µm) and possibly through aerosol. The rate of transmission remains high during airway management. This was evident during the 2003 severe acute respiratory syndrome epidemic where those who were involved in tracheal intubation had a higher risk of infection than those who were not involved (odds ratio 6.6). We describe specific airway management principles for patients with known or suspected COVID-19 disease for an array of critical care and procedural settings. We conducted a thorough search of the available literature of airway management of COVID-19 across a variety of international settings. In addition, we have analyzed various medical professional body recommendations for common procedural practices such as interventional cardiology, gastroenterology, and pulmonology. A systematic process that aims to protect the operators involved via appropriate personal protective equipment, avoidance of unnecessary patient contact and minimalization of periprocedural aerosol generation are key components to successful airway management. For operating room cases requiring general anesthesia or complex interventional procedures, tracheal intubation should be the preferred option. For interventional procedures, when tracheal intubation is not indicated, cautious conscious sedation appears to be a reasonable approach. Awake intubation should be avoided unless it is absolutely necessary. Extubation is a high-risk procedure for aerosol and droplet spread and needs thorough planning and preparation. As updates and modifications in the management of COVID-19 are still evolving, local guidelines, appraised at regular intervals, are vital in optimizing clinical management.Entities:
Mesh:
Year: 2020 PMID: 32502132 PMCID: PMC7288783 DOI: 10.1213/ANE.0000000000005043
Source DB: PubMed Journal: Anesth Analg ISSN: 0003-2999 Impact factor: 6.627
Figure 1.Layout of the airway intervention suite. Adapted and modified from Brewster et al.[13] COVID indicates Coronavirus Disease 2019; HEPA, high-efficiency particulate air.
Aerosol Clearance Timea After Aerosol-Generating Interventions Based on the Air Changes per Hour of a Room[14]
| Air Changesper Hour | Time (min) Needed | Time (min) Needed |
|---|---|---|
| 12 | 23 | 35 |
| 15 | 18 | 28 |
| 20 | 14 | 21 |
| 50 | 6 | 8 |
Institutions may draw up lockdown times based on existing workflows where the doors remain closed for other team members (eg, surgeons). This may not be applicable in emergency situations (eg, an urgent cesarean delivery requiring GETA).
Abbreviation: GETA, general endotracheal tube anesthesia.
aBased on the assumption that aerosol generation has ceased after an intervention,for example, tracheal intubation.
Figure 2.Components of standard airborne precaution personal protective equipment. Adapted and modified from Centers for Disease Control and Prevention.[17]
Figure 3.PPE guidelines for anesthesiologists. AGP indicates aerosol-generating procedure; BiPAP, xxx; COVID-19, Coronavirus Disease 2019; CPAP, xxx; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome Coronavirus 2; SGA, supraglottic airway.
Guidelines to Manage Supply Shortages of PPE, Equipment, and Medications[17,20–26]
| General principles |
| - Limit the exposure of health care workers |
| - Reduce nonessential services |
| - Use of physical barriers such as glass or plastic windows |
| PPE |
| - Extended use of N95 respirators without removing between patient encounters, recommended for 8–12 h. A surgical facemask should be applied over N95 to shield from contamination (grosslycontaminated N95 masks should not be used) |
| - Reprocessed masks |
| - During crisis: portable HEPA filters and ventilated headboards |
| - Reusable water-proof gowns, goggles, and face shields |
| Minimizing medication wastage |
| - Reduce contamination of medications |
| - Beyond-use date (as approved by the United States Pharmacopeia) and sterile compounding outsourced to pharmacy compounders |
| - Regular updates made available locally on available alternatives |
| - Adapting to alternative agents and techniques,for example, induced hypotension with volatile agents instead of propofol |
| - Prepare and store prefilled syringes in small aliquots, for example, fentanyl drawn up from a large volume supply |
| - Pharmacy preparation and storage of prefilled syringes in small aliquots |
| Equipment shortage |
| - Reusing airway equipment with approved disinfection process |
| - Modifications of anesthesia machines as ventilators |
| - Using devices outside their intended use,for example, transport ventilators, sleep apnea machines to assist ventilation, and oxygen concentrators for primary supply |
| Other options reviewed by expert panels: some examples |
| - Masks: repurposeprefabricated snorkel, 3D printed masks |
| - Eye/face shields: sportseye protectors, helmets with visors |
| - Gowns: plasticponchos |
| - Use of nonhuman services: drones and robots |
| - Reduce bulk packaging |
For detailed information, readers should refer to the references quoted. Notably, locally updated guidelines are the best resources in many circumstances.
Figure 4.Airway management for known or suspected COVID-19 patients. COVID indicates Coronavirus Disease 2019; Etco2, xxx; Eto2, expired O2 concentration; ETT, endotracheal tube; HEPA, high-efficiency particulate air; IV, xxx; PPE, personal protective equipment; PPV, positive pressure ventilation; RSI, xxx; SGA, supraglottic airway.